Stem cell transplant efficacy in Parkinson’s disease
Dr E Lane
Applications accepted all year round
Parkinson’s disease is a movement disorder, primarily caused by the loss of nigrostriatal dopamine. Drug therapies are effective in early stages of the disease but new interventions are required in mid to late disease stages.
Cognition and Development in Infants and Children with Chronic Liver Disease
Dr J Day
31 December 2018
Supervisors. Dr Jemma Day, Dr Grainne McAlonan and Dr Jonathan Muircheartaig, Prof Anil Dhawan. Covert hepatic encephalopathy (CHE), a spectrum of neuropsychological problems of patients with chronic liver disease (CLD), is caused by an accumulation of toxic substances that are normally removed by the liver.
Examining the Potential of C-type Lectin-like Receptors (CLRs) as Immunotherapy Targets
Centre for Experimental Medicine
Dr S Orr
20 January 2019
Invasive fungal infections kill more people per year than TB or malaria. Immunosuppressed patients (cancer patients undergoing chemotherapy, acute myeloid leukaemia, HIV, bone marrow transplant patients) are at high risk of developing invasive fungal infections.